Salim, E. I., Elsebakhy, S., & Hessien, M. (2024). Repurposing of atorvastatin and metformin denotes their individual and combined antiproliferative effects in non‐small cell lung cancer. Fundamental & Clinical Pharmacology, 38(3), 550. https://doi.org/10.1111/fcp.12981
Chicago Style (17th ed.) CitationSalim, Elsayed I., Safaa Elsebakhy, and Mohamed Hessien. "Repurposing of Atorvastatin and Metformin Denotes Their Individual and Combined Antiproliferative Effects in Non‐small Cell Lung Cancer." Fundamental & Clinical Pharmacology 38, no. 3 (2024): 550. https://doi.org/10.1111/fcp.12981.
MLA (9th ed.) CitationSalim, Elsayed I., et al. "Repurposing of Atorvastatin and Metformin Denotes Their Individual and Combined Antiproliferative Effects in Non‐small Cell Lung Cancer." Fundamental & Clinical Pharmacology, vol. 38, no. 3, 2024, p. 550, https://doi.org/10.1111/fcp.12981.